# Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study

> **NCT04839913** · — · COMPLETED · sponsor: **University of Cagliari** · enrollment: 121 (actual)

## Conditions studied

- SARS-CoV Infection
- Seroprevalence
- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Antibodies testing

## Key facts

- **NCT ID:** NCT04839913
- **Lead sponsor:** University of Cagliari
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-09-01
- **Primary completion:** 2020-12-10
- **Final completion:** 2021-01-10
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2021-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04839913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04839913, "Seroprevalence of SARS-CoV-2 in Unselected Surgical Patients: an Unicentric, Regional Study". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04839913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*